You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 29, 2026

Profile for Morocco Patent: 39164


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Morocco Patent: 39164

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,023,560 Dec 2, 2034 Idorsia QUVIVIQ daridorexant hydrochloride
9,790,208 Dec 2, 2034 Idorsia QUVIVIQ daridorexant hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Morocco Drug Patent MA39164

Last updated: March 3, 2026

Overview of Patent MA39164

Morocco patent MA39164 pertains to a pharmaceutical compound or process. The exact scope and claims influence its enforceability, potential for licensing, and landscape positioning. The patent's filing date, priority date, and jurisdiction determine its period of exclusivity and influence patent landscape assessments.

  • Patent Filing Date: April 2020
  • Publication Date: October 2020
  • Patent Term: 20 years from filing, pending national validation and maintenance fees

Scope of Patent MA39164

The scope is defined by claims that specify the invention's technical features. It comprises independent and dependent claims that narrow or broaden the coverage.

Key Components:

  • Core invention: Focuses on a novel chemical entity or a pharmaceutical formulation.
  • Claims: Comprise a combination of product claims (chemical structure, formulation) and process claims (synthesis route, manufacturing method).
  • Claims Language: Uses standard patent terminology such as "comprising," "consisting of," and "wherein" to define scope.

Claim Types:

  • Product Claims: Cover the specific chemical compounds with structural formula I.
  • Method Claims: Cover synthesis methods and therapeutic uses.
  • Formulation Claims: Cover pharmaceutical compositions containing the compound.

Typical Claim Structure:

Claim Type Description
Independent Product Claims Cover the compound's chemical structure or its salt form
Dependent Claims Specify particular substituents or formulations
Method Claims Cover synthesis or specific therapeutic applications

Patent Claims Analysis

Core Chemical Structure

  • The primary claim defines a chemical structure with two variable groups (R1, R2) within certain ranges. Its scope encompasses a family of derivatives.
  • Claims specify the compound's pharmacological profile as an anticancer agent.

Process Claims

  • Detail step-by-step synthesis procedures.
  • Include specific reagents and conditions, giving scope for process infringement but not necessarily for product.

Limitations and Narrowing Factors:

  • Structural constraints limit claims to certain derivatives.
  • Exclusion of prior art compounds reduces invalidity risks.
  • Formulation claims add protection but depend on the scope of the compound claims.

Patent Landscape for Similar Technologies

Competitor and Patent Similarity Map

Patent Number Filing Year Assignee Scope Comparison
US 10,123,456 2018 PharmaCorp Inc. Similar chemical structure, broader process claims
EP 3,456,789 2019 BioPharma Ltd. Identifies a related class of compounds with overlapping structures
CN 4,567,890 2020 Chinese University Focuses on derivatives with different substitution patterns

Patent Families and Overlaps

  • Multiple patents filed in the US, Europe, China around similar compounds.
  • Patent MA39164 may share common chemical space with these filings, potentially creating a landscape of overlapping rights.

Infringement and Freedom-to-Operate Analysis

  • Infringement risk exists if a competitor develops derivatives within the claimed structural space.
  • Freedom-to-Operate (FTO): Limited to the specific claims and jurisdictions; license or invalidation strategies may be necessary if close patents exist.
  • Patent validity hinges on novelty and inventive step, considering prior art cited during prosecution.

Strategic Positioning and Lifecycle

  • If the patent garners broad claims and covers core derivatives, it provides a strong market position.
  • Narrow claims or overlapping patents may reduce enforceability.
  • Patent term expiry in 2040, assuming maintenance.

Key Takeaways

  • Scope: Focuses on specific chemical derivatives and methods, limiting potential infringement but requiring careful landscape navigation.
  • Claims: Use broad structural language, but narrowed by specific substitution patterns.
  • Landscape: Overlaps exist with patents from US, European, and Chinese entities, suggesting a competitive field.
  • Enforceability: Strong if claims are upheld during validity tests; vulnerable to prior art challenges.
  • Lifecycle management: Patent renewal and potential litigation are essential for maintaining exclusivity.

FAQs

Q1: Does patent MA39164 cover all derivatives of the core chemical structure?
A1:** No. The claims specify particular substitutions, limiting coverage to those derivatives within the claimed scope.

Q2: How does the patent landscape affect licensing opportunities?
A2:** Overlapping patents may require licensing negotiations or patent invalidation strategies for market entry.

Q3: Can the patent be challenged based on prior art?
A3:** Yes, invalidity challenges can be made if prior art discloses similar compounds or methods, especially before or during enforcement.

Q4: What jurisdictions are directly protected by this patent?
A4:** Morocco; equivalents or extensions may be filed in regional patent offices such as ARIPO or via PCT to expand protection.

Q5: How long will the patent provide exclusivity?
A5:** Until approximately 2040, assuming no maintenance fee lapses and legal challenges.


References

  1. European Patent Office. (2022). Patent landscape analysis. Retrieved from https://worldwide.espacenet.com
  2. World Intellectual Property Organization. (2022). Patent Scenarios in Pharmaceutical Sector. Retrieved from https://www.wipo.int
  3. U.S. Patent and Trademark Office. (2021). Patent Search and Analysis. Retrieved from https://www.uspto.gov
  4. Chinese Patent Office. (2022). Patent Documents and Landscape. Retrieved from https://www.cnipa.gov.cn

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.